title: The 20th International AIDS Conference: where do we go from here?
authors.affiliation: McGill University AIDS Centre, Jewish General Hospital, Montreal, QC, Canada; Journal of the International AIDS Society, Geneva, Switzerland; mark.wainberg@mcgill.ca.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
authors.affiliation: Journal of the International AIDS Society, Geneva, Switzerland; Social Policy Research Centre, University of New South Wales, Sydney, Australia.
authors.forename: Susan
authors.initials: S
authors.lastname: Kippax
authors.affiliation: Journal of the International AIDS Society, Geneva, Switzerland.
authors.forename: Marlene
authors.initials: M
authors.lastname: Bras
authors.affiliation: Journal of the International AIDS Society, Geneva, Switzerland; Department of Infectious Diseases, University of Dakar, Dakar, Senegal.
authors.forename: Papa
authors.initials: P
authors.lastname: Salif Sow
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D003140:Communicable Disease Control / Q000379:methods*; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D014943:Global Health; D006291:Health Policy; D006801:Humans; D008297:Male
chemical_list: D044966:Anti-Retroviral Agents